Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Gains from Investment Securities (2016 - 2026)

Amphastar Pharmaceuticals has reported Gains from Investment Securities over the past 13 years, most recently at $434000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 88.23% year-over-year to $434000.0; the TTM value through Dec 2025 reached $15.7 million, down 10.82%, while the annual FY2025 figure was $24036.0, 99.64% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $434000.0 at Amphastar Pharmaceuticals, down from $6.9 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $12.2 million in Q1 2022 and troughed at $2206.0 in Q1 2025.
  • A 5-year average of $3.7 million and a median of $3.0 million in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: surged 5104.33% in 2021 and later tumbled 99.62% in 2025.
  • Year by year, Gains from Investment Securities stood at $7.8 million in 2021, then tumbled by 85.28% to $1.1 million in 2022, then surged by 368.12% to $5.4 million in 2023, then tumbled by 31.39% to $3.7 million in 2024, then plummeted by 88.23% to $434000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for AMPH at $434000.0 in Q4 2025, $6.9 million in Q3 2025, and $11420.0 in Q2 2025.